Tech Company Financing Transactions
Erasca Funding Round
Erasca, operating out of San Diego, raised $36 million from OrbiMed and Partner Fund Management.
Transaction Overview
Company Name
Announced On
9/2/2020
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series B
Investors
Partner Fund Management (Mark Karvosky)
Proceeds Purpose
Erasca will use the proceeds to finance the clinical development of multiple promising oncology programs, continue driving corporate development efforts and further advance the company's in-house drug discovery pipeline.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 140
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Our mission at Erasca is embedded in our name: To erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Varney
Chief Executive Officer
Jonathan Lim
Chief Operating Officer
Gary Yeung
General Manager
Jen Majeti
Vice President
Les Brail
Vice President
Robert Shoemaker
Vice President
Jean Vernier
VP - Bus. Development
David Chacko
VP - Finance
Karen Gilmore
VP - Operations
David Luo
VP - Regulatory Affairs
Bao Truong
Browse more venture capital transactions:
Prev: 9/2/2020: Headset venture capital transaction
Next: 9/2/2020: Hazel Health venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs